Sensitivity to PAF Is Increased in Migraine Patients

• References

• 1 Chapman LF, Ramos AO, Goodell H, Silverman G, Wolff HG. A humoral agent implicated in vascular headache of the migrainous type. Arch Neurol 1960; 3: 223
• 2 Benveniste J, Henson PM, Cochrane CG. Leucocyte-dependent histamine release from rabbit platelets: The role of IgE, basophils and a platelet-activating factor. J Exp Med 1972; 136: 1356
• 3 Chignard M, LeCouedic JP, Tence M, Vargaftig BB, Benveniste J. The role of platelet-activating factor in platelet aggregation. Nature 1979; 279: 799-800
• 4 Morley J, Sanjar S, Page CP. The platelet in asthma. Lancet 1984; 2: 1142-1144
• 5 Grandel KE, Farr RS, Wandere AA, Eisenstadt TC, Wasserman SI. Association of platelet-activating factor with primary acquired cold urticaria. New Eng J Med 1985; 313: 405-409
• 6 Kloprogge E, Akkerman JN. Binding kinetics of PAF-acether (1-o-alleyl-2-acetyle-sn-glycero-3-phosphocholine) to intact human platelets. Biochem J 1984; 223: 901-909
• 7 Vahlquist B. Migraine and children. Int Arch Allergy 1955; 7: 348-355
• 8 Born G VR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927
• 9 Joseph R, Steiner TJ, Schultz L UC, Rose FC. Does the mode of action of B-blockers in migraine involve alteration of platelet function?. In Migraine Clinical and Research Advances. pp. 115-120 Rose FC. (ed.). Karger; Basel: 1985
• 10 Komecki E, Ehrlich YH, Lenox RH. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. Science 1984; 226: 1454-1456
• 11 Shen TY, Hwang SB, Chang MN, Doebber TW, Lam MT, Wu MS, Wang X, Han GQ, Li RZ. Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. Proc Natl Acad SCI USa 1985; 82: 672-676